This note conversion penalty issue lays at the fee
Post# of 144876
![Avatar](/images/ProfileImages/883511230_63069_treesquare.jpg)
I have brought up a concern of mine in the past and the permabulls have always shot me down with excuses defending it. But the $22M penalty is exhibit A
Q. If they can't get a loan right then what makes anyone think they can prevail against a big pharma deal with hoards of lawyers and decades of medical contract law experience.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)